Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin
Condition(s):Hiv; TuberculosisLast Updated:November 13, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Hiv; TuberculosisLast Updated:November 13, 2023Active, not recruiting
Condition(s):Pediatric HIV Infection; Latent TuberculosisLast Updated:February 28, 2024Not yet recruiting
Condition(s):HIV Infections; TuberculosisLast Updated:September 18, 2023Completed
Condition(s):HIVLast Updated:October 1, 2015Completed
Condition(s):HIV-1-infection on Healthy VolunteersLast Updated:March 5, 2024Completed
Condition(s):Human Immunodeficiency VirusLast Updated:January 28, 2020Completed
Condition(s):HIV-1-infection; Hepatic ImpairmentLast Updated:June 10, 2021Withdrawn
Condition(s):HIV InfectionsLast Updated:July 14, 2020Completed
Condition(s):HIVLast Updated:December 29, 2022Terminated
Condition(s):HIVLast Updated:November 20, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.